| | CASMASCI | progen | BOC | 進口現貨產品 | 胎牛血清 | 細胞培養 | 提取試劑 | 轉染試劑 | 常規生化試劑 | ELISA試劑盒 | 抗體 | 細胞因子 | sigma aldrich(西格瑪) | Invitrogen(英駿) | Millipore | Abcam | CST | Roche | peprotech | prospec | pierce | BD Pharmingen | BD Biocoat | R&D | BioVision | Vector | Enzo life | eBioscience | ABR | Amresco | Cayman Chemical | 脂蛋白 | Merck | Qiagen(凱杰) | Santa cruz(三塔抗體) |
產品名稱:Anti-Human CD267 (TACI) PE (11H3) 25 tests
產品貨號:eBioscience 12-9217-41
產品規格:25 tests
Anti-Human CD267 (TACI) PE
Also known as: TNFRSF13B
Clone: 11H3
RUO: For Research Use Only. Not for use in diagnostic procedures.
SKU# 12-9217
Cat. No. Size
12-9217-41 25 tests
12-9217-42 100 tests
Description: The 11H3 antibody reacts with human TACI, also known as tumor necrosis factor receptor 13B. TACI, like BCMA, binds BAFF and April. TACI and its ligands regulate humoral immune responses, activate NF-kB and c-jun N-terminal kinase, and are involved in B cell associated autoimmune diseases. TACI mRNA and protein are found predominantly in B-cells and correlate with BLyS binding in a panel of B-cell lines. TACI interacts with nanomolar affinity with the BLyS-related tumor necrosis factor homologue APRIL for which no clear in vivo role has been described. 11H3 does not block binding of BAFF/BLyS to TACI.